A gathering of the Africa Union and Africa CDC united Africa heads of States in a meeting to generate new ideas over the landmasses readiness or absence of it in battling COVID-29.
Confronted with what it is portrayed as antibody nationalization and fare limitations on drugs items, Africa is feeling uncovered inciting the need to push for an African-based arrangement
South Africa and Rwanda have effectively made strong strides towards the assembling of COVID-19vaccines inside the landmass.
The two countries have gone into organization manages Johnson and Johnson, Moderna and Pfizer to start immunization creations in their nations
“We will begin creation of 220 million dosages in an arrangement with Johnson and Johnson,” South Africa’s President Cyril Ramaphosa said on Monday.
As indicated by President Robert Kagame, Rwanda is in converses with Moderna and Pfizer Biontech for the creation of the antibodies.
African nations have been receiving their vaccines through UNICEF in a partnership agreement with GAVI—but given COVID-19 pandemic ravaging the Western nations, European countries have limited export and imposed bans on the vaccines giving priority to their citizens.
The World Health Organization (WHO) has set up a COVAX manufacturing task force to boost COVID-19 vaccine supply and build sustainable manufacturing to support health security.
The who boss is appealing to global pharmaceutical companies to share their know how on vaccine production
The virtual AU meeting brought together Heads of States from Rwanda, South Africa, Congo, and Senegal.
The WHO and the World Trade Organization bosses were also in attendance.
Africa’s nations are citing lack of capital, lack of standards of quality for such products, technological challenges among other parameters as factors that have condemned the continent to lag behind in the vaccine production